Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Compound for inhibiting binding between DX2 protein and p14/ARF protein, and pharmaceutical composition for treating or preventing cancer disease containing same as effective ingredient

US Patent 10280178 · Granted May 7, 2019

Assignee

Inventors

View full patent text on Google Patents →